Press Releases

2019

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Denali Therapeutics Announces First Patient Dosed In Phase 1b Study Of DNL151 For Parkinson’s Disease And Launch Of Its Engage Parkinson’s Website

Denali Therapeutics 09.04.2019

Denali Therapeutics Announces That Its Partner Sanofi has Commenced Dosing of DNL758 in a Phase 1 Study

Denali Therapeutics 08.05.2019

Denali Therapeutics Announces First Patient Dosed In Phase 1b Study Of DNL747 For Alzheimer’s Disease

Denali Therapeutics 02.15.2019

SIRION Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System

Denali Therapeutics 01.09.2019

Denali Therapeutics Announces First Patient Dosed in Phase 1B Study of DNL747 for ALS

Denali Therapeutics 01.08.2019

Loading